"At Assil Eye Institute we are dedicated to providing our patients with the best medical care available in a compassionate and caring atmosphere. If you are seeking a LASIK specialist, the doctors at Assil Eye Institute would like to offer you world class eye care and vision correction. Brought to you by Los Angeles LASIK expert, Kerry K. Assil, MD, you will experience a one of a kind medical facility that brings the best technology with only the most experienced hands in ophthalmology. Helping you achieve your personal best vision is mission critical at our Beverly Hills LASIK office. As the official LASIK and cataract surgeons of the Los Angeles Lakers and winners of the Beverly Hills Chamber of Commerce Business Excellence Award our pa..."

During the past decade, Assil Eye Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Assil Eye Institute" #1 sponsor was "Abbott Medical Optics" with 2 trials, followed by "Heidelberg Engineering GmbH" with 2 trials sponsored, "Allergan" with 1 trials sponsored, "Glaukos Corporation" with 1 trials sponsored and "Kerry Assil, MD" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

According to Clinical.Site data, the most researched conditions in "Assil Eye Institute" are "Cataract" (2 trials), "Glaucoma" (2 trials), "Presbyopia" (2 trials), "Aphakia" (1 trials) and "Glaucoma, Open-Angle" (1 trials). Many other conditions were trialed in "Assil Eye Institute" in a lesser frequency.

Most popular intervention types in "Assil Eye Institute" are "Device" (8 trials), "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Artisan Aphakia Intraocular Lens" (1 trials), "Cataract surgery only" (1 trials), "Corneal inlay" (1 trials), "Dextenza 0.4Mg Ophthalmic Insert" (1 trials) and "Heidelberg Spectralis OCT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Assil Eye Institute" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Assil Eye Institute". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Assil Eye Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Assil Eye Institute, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".